Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se-Ik Kim

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Cancer Research and Treatment|July 29, 2020
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in KoreaSe Ik Kim, Maria Lee, Hee Seung Kim, et al.
Cancer Science|March 3, 2024
Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activationJuwon Lee, Youngjin Han, Soochi Kim, et al.
Cancer Research and Treatment|October 24, 2025
Disease Burden and Treatment Pattern of Advanced or Recurrent Endometrial Cancer in Korea: A Nationwide Database (DIRECTION) StudyHyun-Woong Cho, Se Ik Kim, Min-Ji Bae, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 13, 2023
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organizationDavid Tan, Noriko Fujiwara, Keiichi Fujiwara, et al.
Journal of Gynecologic Oncology|February 28, 2025
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort studyBo Ra Kim, Se Ik Kim, Sang Wun Kim, et al.
Cancer Research and Treatment|November 8, 2024
Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective StudyYoung Wook Jeong, Dongkyu Eugene Kim, Ji Hyun Kim, et al.
Cancers|July 13, 2024
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP InhibitorsJi Hyun Kim, Eun Taeg Kim, Se Ik Kim, et al.
Oncogene|August 15, 2019
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cellsYoungjin Han, Boyun Kim, Untack Cho, et al.
Journal of Gynecologic Oncology|September 19, 2025
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organizationDavid Tan, Noriko Fujiwara, Keiichi Fujiwara, et al.
Journal of Gynecologic Oncology|March 8, 2024
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023Heng-Cheng Hsu, Jae-Weon Kim, Jeong-Yeol Park, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Cancer Research and Treatment|July 29, 2020
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in KoreaSe Ik Kim, Maria Lee, Hee Seung Kim, et al.
Cancer Science|March 3, 2024
Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activationJuwon Lee, Youngjin Han, Soochi Kim, et al.
Cancer Research and Treatment|October 24, 2025
Disease Burden and Treatment Pattern of Advanced or Recurrent Endometrial Cancer in Korea: A Nationwide Database (DIRECTION) StudyHyun-Woong Cho, Se Ik Kim, Min-Ji Bae, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 13, 2023
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organizationDavid Tan, Noriko Fujiwara, Keiichi Fujiwara, et al.
Journal of Gynecologic Oncology|February 28, 2025
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort studyBo Ra Kim, Se Ik Kim, Sang Wun Kim, et al.
Cancer Research and Treatment|November 8, 2024
Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective StudyYoung Wook Jeong, Dongkyu Eugene Kim, Ji Hyun Kim, et al.
Cancers|July 13, 2024
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP InhibitorsJi Hyun Kim, Eun Taeg Kim, Se Ik Kim, et al.
Oncogene|August 15, 2019
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cellsYoungjin Han, Boyun Kim, Untack Cho, et al.
Journal of Gynecologic Oncology|September 19, 2025
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organizationDavid Tan, Noriko Fujiwara, Keiichi Fujiwara, et al.
Journal of Gynecologic Oncology|March 8, 2024
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023Heng-Cheng Hsu, Jae-Weon Kim, Jeong-Yeol Park, et al.
Pageof 15